This leads to the activation of NF-κB, a key pro-inflammatory transcription factor [59], and increased production of pro-inflammatory cytokines, thus creating an inflammatory milieu with tumour-promoting effect, that further triggers signalling pathways, such as MAPK/ERK or PI3K/AKT/mTOR [58,60]. The gene discussed is AKT1; the disease is neoplasm.